16,108例受检病例与18,038例对照的年龄相关性黄斑变性多 ancestry 全基因组关联研究
该研究纳入经眼科确认的晚期年龄相关性黄斑变性(adAMD)病例16,108例和无AMD对照18,038例,涵盖四种 ancestry,通过TOPMedv2填充进行跨 ancestry 全基因组关联分析。研究识别出28个达到P < 5 × 10⁻⁸的位点,包括较IAMDGC 1.0新增的SERPINA1和CPN1两个位点;含52个变异和不含CFH的44个变异遗传风险评分在所有 ancestry 中均可预测adAMD。
要点
- 跨 ancestry 分析识别28个adAMD相关位点,较IAMDGC 1.0新增SERPINA1和CPN1两个位点。
- 52变异遗传风险评分在所有 ancestry 中预测adAMD的AUC为0.80/0.75、0.65/0.64和0.80/0.79。
- CFH变异在特定 ancestry 中相关性较低,提示不同 ancestry 间致病负担存在差异。
核心结论
- adAMD的遗传基础在各 ancestry 之间大部分共享。
- CFH变异在特定 ancestry 中相关性较低,提示不同 ancestry 间致病负担存在差异。
- IAMDGC 2.0填充使可用AMD基因组数据增加超过300倍,成为后续AMD遗传分析的有价值资源。
研究设计与样本
- IAMDGC 2.0分析纳入经眼科确认的adAMD病例16,108例和无AMD对照18,038例,涵盖男性和女性及四种 ancestry,通过定制外显子芯片经TOPMedv2填充进行全基因组分析,数据分析时间为2021年6月至2024年5月。
主要发现
- 跨 ancestry 数据(病例/对照:欧洲15,616/16,723、非洲50/357、亚洲207/322、其他235/636)识别28个P < 5 × 10⁻⁸的位点,包括较IAMDGC 1.0新增的SERPINA1和CPN1两个AMD位点。
- 精细定位支持HTRA1/ARMS2周围一个 ancestry 共享信号和CFH周围九个信号,无非洲 ancestry 贡献。
- 52变异遗传风险评分在所有 ancestry 中预测adAMD的AUC为0.80/0.75、0.65/0.64和0.80/0.79。
- 不含CFH的44变异评分在所有 ancestry 中预测adAMD的AUC为0.80/0.79(对应上述三种 ancestry 顺序)。
关键数值与推荐
- 44变异遗传风险评分(不含CFH)预测adAMD的AUC在三种 ancestry 分别为0.80/0.79(对应含CFH评分的三种 ancestry 顺序)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In 2016, the International Age-related Macular Degeneration Genomics Consortium analyzed data from approximately 50,000 individuals (IAMDGC 1.0) and identified 52 variants across 34 loci associated with advanced AMD (adAMD) in individuals of European ancestry and did not include diverse ancestries, fine-mapping per ancestry, or a predictive model with/without the contributions of one lead genetic risk locus, CFH. Therefore, we analyzed full cross-ancestry IAMDGC data, utilizing the newest imputation panel, and identified genetic risk loci across and between ancestries contributing to AMD. METHODS: In this IAMDGC 2.0 analysis, we included cross-ancestry data via custom exome chip imputed genome-wide via TOPMedv2, in 16,108 ophthalmologically confirmed adAMD cases and 18,038 examined AMD-free controls. We included both male and female subjects and four diverse ancestries. Data were analyzed from June 2021 to May 2024. RESULTS: Utilizing diverse ancestry data (cases/controls = 15,616/16,723 European, 50/357 African, 207/322 Asian, and 235/636 Other), we identified 28 loci at P < 5 × 10-8, including 2 additional AMD loci compared to IAMDGC 1.0 (SERPINA1 and CPN1). Fine-mapping supported one ancestry-shared signal around HTRA1/ARMS2 and nine signals around CFH without African ancestry contribution. The 52-variant genetic risk score with and the 44-variant score without CFH predicted adAMD in all ancestries (area under the curve [AUC] = 0.80/0.75, 0.65/0.64, and 0.80/0.79, respectively). CONCLUSIONS: Our results indicate that the genetic underpinning of adAMD is mostly shared between ancestries. We also identify the CFH variant as being less relevant in specific ancestries, indicating a difference in pathogenic burden between ancestries. We increased the available genomic data for AMD over 300-fold with the IAMDGC 2.0 imputation, making it a valuable resource for further AMD genetic analysis.
引用
- Gorski M, Grunin M, Herold JM, et al. Diverse-Ancestry GWAS of Age-Related Macular Degeneration on 16,108 Examined Cases and 18,038 Controls. Invest Ophthalmol Vis Sci. 2025. PMID: 41159651. doi:10.1167/iovs.66.13.51
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。